Skip to main content

Research News

  • Study Details How Cancer Cells Fend Off Starvation & Death from Chemotherapy

    Laboratory experiments with cancer cells reveal two ways in which tumors evade drugs designed to starve and kill them, a new study shows.

  • Cervical cancer deaths in young women plummet after introduction of HPV vaccine

    Cervical cancer deaths have plunged dramatically among women under age 25, and researchers at MUSC Hollings Cancer Center believe this is likely due to HPV vaccination. Their study, published in JAMA, is the first to suggest the impact of HPV vaccination on cervical cancer deaths.

  • Drug research: decoding the structure of nano gene ferries
    Cationic polymers are promising tools for transporting RNA therapeutics or RNA vaccines. Like lipid nanocarriers, they are used to deliver mRNA medicines. The nanoscopic packaging materials are able to effectively protect their load and deliver them to the target cells.
  • Probiotic delivers anticancer drug to the gut

    Immunotherapy is a promising treatment that recruits the immune system to help fight cancer, but it has had limited success in gastrointestinal cancers. Now, researchers at Washington University School of Medicine in St. Louis have engineered a probiotic that delivers immunotherapy directly to the gut to shrink tumors in mice, offering a potentially promising oral drug for hard-to-reach cancers.

  • Stopping severe malaria by harnessing natural human antibodies

    Malaria, particularly in its severe forms, remains a global health and economic burden. It causes the deaths of more than 600,000 people every year – most of them African children under five. In a new study, published in the journal Nature, researchers from EMBL Barcelona, the University of Texas, the University of Copenhagen, and The Scripps Research Institute have discovered human antibodies that can recognise and target some of the proteins that cause severe malaria. This breakthrough could pave the way for future vaccines or anti-malaria treatments.

  • Tumor Cells Suffer Copper Withdrawal Nanofibers made of copper-binding peptides disrupt copper homeostasis in cancer cells

    While toxic in high concentrations, copper is essential to life as a trace element. Many tumors require significantly more copper than healthy cells for growth a possible new point of attack for cancer treatment. In the journal Angewandte Chemie, a research team from the Max Planck Institute for Polymer Research has now introduced a novel method by which copper is effectively removed from tumor cells, killing them.

  • Optical Biosensor Rapidly Detects Monkeypox Virus
    A new variant of human mpox has claimed the lives of approximately 5% of people with reported infections in the Democratic Republic of the Congo since 2023, many of them children. Since then, it has spread to several other countries. The World Health Organization declared the outbreak a Public Health Emergency of International Concern on August 14. In addition, a different but rarely fatal mpox variant was responsible for an outbreak that has spread to more than 100 countries since 2022.
  • New Discovery Enables Gene Therapy for Muscular Dystrophies, Other Disorders

    RNA-based technology facilitates effective use for difficult-to-treat, large-gene diseases. Gene therapy can effectively treat various diseases, but for some debilitating conditions like muscular dystrophies there is a big problem: size. The genes that are dysfunctional in muscular dystrophies are often extremely large, and current delivery methods can’t courier such substantial genetic loads into the body.

  • Aptar Pharma to Commercialize Quattrii Dry Powder Inhaler Platform
    Aptar Pharma, a global leader in drug delivery and active material science solutions and services, today announced that it has entered into an exclusive collaboration agreement with Cambridge Healthcare Innovations to lead the commercialization and promotion of its Quattrii Dry Powder Inhaler platform.
  • Researchers develop nanofiber patch for treatment of psoriasis
    Researchers at the University of Copenhagen have developed a patch for easier and more effective treatment of psoriasis. The method may also be used in treatment of other inflammatory skin diseases.
Subscribe to Research News